This research is being done to see how well the combination of a standard of care drug,
investigational drug, and radiation therapy work against unresectable vulvar squamous cell
carcinoma.
This research study involves the following:
- Cisplatin (standard of care drug)
- Pembrolizumab (investigational drug)
- Radiation Therapy (standard of care intervention)